Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN): response to Knopp.

Gazi Irene F, Mikhailidis Dimitri P

Diabetes Care. 2006 Nov;29(11):2561; author reply 2561-2. doi: 10.2337/dc06-1487.

Abstract

摘要

相似文献

Diabetes Care. 2006 Nov;29(11):2561; author reply 2561-2. doi: 10.2337/dc06-1487.

Diabetes Care. 2006 Jul;29(7):1478-85. doi: 10.2337/dc05-2415.

Lancet. 2004;364(9435):685-96. doi: 10.1016/S0140-6736(04)16895-5.

Dtsch Med Wochenschr. 2004 Sep 10;129(37):1944. doi: 10.1055/s-2004-831832.

Lancet. 2004;364(9449):1933-4. doi: 10.1016/S0140-6736(04)17464-3.

ACP J Club. 2004 Mar-Apr;140(2):A16; author reply A16.

Angiology. 2003 Nov-Dec;54(6):679-90. doi: 10.1177/000331970305400607.

Lancet. 2004;364(9449):1933; author reply 1933. doi: 10.1016/S0140-6736(04)17462-X.

Int J Clin Pract. 2005 Jan;59(1):124; author reply 124. doi: 10.1111/j.1742-1241.2005.0397a.x.

Geriatr Gerontol Int. 2012 Apr;12 Suppl 1:88-102. doi: 10.1111/j.1447-0594.2011.00816.x.

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。